A new vaccine therapy developed by Stanford University School of Medicine researchers may someday provide hope for cancer patients.

Working with mice, the scientists injected minute doses of two vaccines, they created, directly into solid tumors that had developed in the animals.

Stanford University professor of oncology, Dr. Ronald Levy, MD, is the senior author of a study that outlines the research team’s findings.

According to the study, this vaccine can treat many different types of cancers.

He says the two-part vaccine treatment stimulates the immune cells only within the tumor itself.

But, the researchers observed effects that included the elimination of tumors all over the animal.

A human clinical trial to test the effect of the treatment in lymphoma patients began in January.

The study was published on January 31, 2018, in the journal, Science Translational Medicine.